Artelo Biosciences Files Form D for Exempt Offering
Ticker: ARTL · Form: D · Filed: Apr 6, 2026 · CIK: 0001621221
Sentiment: neutral
Topics: exempt-offering, capital-raise, form-d
TL;DR
ARTLO filed a D for exempt offering, raising capital.
AI Summary
Artelo Biosciences, Inc. filed a Form D on April 6, 2026, to announce an exempt offering of securities. The company is located at 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075. This filing relates to the Securities Act of 1933.
Why It Matters
This filing indicates Artelo Biosciences is raising capital through an exempt offering, which could signal growth or funding needs for its pharmaceutical preparations business.
Risk Assessment
Risk Level: medium — Form D filings indicate a company is raising capital, which can be a positive sign but also carries inherent risks associated with new investments and company performance.
Key Players & Entities
- ARTELO BIOSCIENCES, INC. (company) — Filer
- 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 (address) — Mailing and Business Address
- 0001621221 (company_id) — CIK
- 331220924 (tax_id) — EIN
- NV (state) — State of Incorp.
- 1231 (date) — Fiscal Year End
- D (form_type) — Form Type
- 33 (act) — Securities Act
- 021-579170 (file_number) — File Number
- 26840290 (film_number) — Film Number
FAQ
What type of securities offering is Artelo Biosciences, Inc. filing?
Artelo Biosciences, Inc. is filing a Form D, which is a Notice of Exempt Offering of Securities.
When was this Form D filing accepted by the SEC?
The Form D filing was accepted on April 6, 2026.
What is the business address of Artelo Biosciences, Inc.?
The business address is 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075.
In which state was Artelo Biosciences, Inc. incorporated?
Artelo Biosciences, Inc. was incorporated in Nevada (NV).
What is the SIC code listed for Artelo Biosciences, Inc.?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,482 words · 6 min read · ~5 pages · Grade level 15.9 · Accepted 2026-04-06 12:57:38
Key Financial Figures
- $1 — enues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,
- $1,000,000 — No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,
- $5,000,000 — Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001
- $1,000,001 — e $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000
- $5,000,001 — $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
- $25,000,000 — $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001
- $25,000,001 — $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
- $50,000,000 — 5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,0
- $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $1
- $50,000,001 — 0,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 O
- $85,000 — ants with an expense allowance of up to $85,000 and 5.5-year warrants to acquire 255,07
- $4.3125 — of common stock at an exercise price of $4.3125 per share. 16. Use of Proceeds
Filing Documents
- primary_doc.html (D)
- primary_doc.xml (D) — 12KB
- 0001621221-26-000005.txt ( ) — 13KB
From the Filing
Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type REACTIVE MEDICAL INC. KNIGHT KNOX DEVELOPMENT CORP. Corporation Limited Partnership Limited Liability Company General Partnership Business Trust Other Name of Issuer ARTELO BIOSCIENCES, INC. Jurisdiction of Incorporation/Organization NEVADA Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer ARTELO BIOSCIENCES, INC. Street Address 1 Street Address 2 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CALIFORNIA 92075 858-925-7049 3. Related Persons Last Name First Name Middle Name Gorgas Gregory D. Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Matsui Connie Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Blayney Douglas Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Kelly Steven Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Emanuele R. Martin Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Favorito Tamara A. Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Reyes Gregory R. Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Last Name First Name Middle Name Spring Mark Street Address 1 Street Address 2 c/o Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160 Solana Beach CALIFORNIA 92075 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) 4. Industry Group Agriculture Banking & Financial Services Commercial Banking Insurance Investing Investment Banking Pooled Investment Fund Other Banking & Financial Services Business Services Energy Coal Mining Electric Utilities Energy Conservation Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other Health Care Manufacturing Real Estate Commercial Construction REITS & Finance Residential Other Real Estate Retailing Restaurants Technology Computers Telecommunications Other Technology Travel Airlines & Airports Lodging & Conventions Tourism & Travel Services Other Travel Other 5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 Over $100,000,000 Decline to Disclose Decline to Disclose Not Applicable Not Applicable 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b) Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) 7. Type of Filing New Notice Date of First Sale 2026-03-27 First Sale Yet to Occur Amendment 8.